Galera Therapeutics, Inc.

Distress signal

Moderate confidence (50%)

Updated Oct 19, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Galera Therapeutics, Inc. deregistered its securities (Aug 4, 2026)

Every material event, newest first. History is never overwritten.

Galera Therapeutics, Inc. deregistered its securities
Aug 4, 2026
Registration withdrawn
- SEC EDGAR — “15-12G 1 d29107d1512g.htm 15-12G 15-12G As filed with the Securities and Exchange Commission on August 4, 2026 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-39114 Galera Therapeutics, Inc. (Exact name of registrant as specified in its charter) 101 Lindenwood Drive, Suite 225 Malvern, PA 19355 (610) 725-1500 (Address…”
Galera Therapeutics, Inc. received a delisting notice from its exchange
Aug 3, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing The information set forth in Item 2.01 of this Current Report on Form 8-K regarding the Mergers is incorporated by reference into this Item 3.01. In connection with the consummation of the Mergers, the Company expects that the Galera Common Stock will cease to be quoted on the OTCQB Market. The Company intends to file a Certification and Notice of Termination of Registration on Form 15 with the SEC after the close of trading on August 3, 2026 to terminate the registration of Galera Com…”

Every material source used to build this profile.

SEC Company Submissions (TIER 1 · UNVERIFIED)
Galera Therapeutics, Inc. — Pharmaceutical Preparations (SIC 2834) — MALVERN, PA
View source record
SEC EDGAR (TIER 1 · UNVERIFIED)
15-12G 1 d29107d1512g.htm 15-12G 15-12G As filed with the Securities and Exchange Commission on August 4, 2026 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-39114 Galera Therapeutics, Inc. (Exact name of registrant as specified in its charter) 101 Lindenwood Drive, Suite 225 Malvern, PA 19355 (610) 725-1500 (Address…
View source record
SEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing The information set forth in Item 2.01 of this Current Report on Form 8-K regarding the Mergers is incorporated by reference into this Item 3.01. In connection with the consummation of the Mergers, the Company expects that the Galera Common Stock will cease to be quoted on the OTCQB Market. The Company intends to file a Certification and Notice of Termination of Registration on Form 15 with the SEC after the close of trading on August 3, 2026 to terminate the registration of Galera Com…
View source record

Every derived status, with the rule that produced it.

DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:33 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:13 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:34 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:14 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:32 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:32 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.